Company Overview
About Sidewinder Therapeutics
Sidewinder Therapeutics is developing conditionally activated cancer therapeutics — drugs engineered to remain inert in circulation and become pharmacologically active only when they reach the tumor microenvironment. The approach exploits the unique biochemical conditions of solid tumors (acidic pH, hypoxia, tumor-specific proteases) to trigger drug activation, allowing far higher doses to be delivered to tumors with dramatically reduced side effects in healthy tissues.
Business Model & Competitive Advantage
Founded in 2021 by chemical biology and oncology drug design veterans, Sidewinder's platform applies to multiple drug classes including kinase inhibitors, ADC payloads, and immune checkpoint modulators. The $100M Series A in 2025 funds advancement of lead programs in pancreatic cancer and triple-negative breast cancer — two tumor types with few effective treatment options where toxicity limits standard-of-care dosing.
Competitive Landscape 2025–2026
The conditional activation concept has been validated by FDA approval of DRP-104 and advancement of prodrug candidates at Arcus Biosciences and Spring Bioscience, but Sidewinder's platform claims broader applicability across drug classes and tumor types. Reducing chemotherapy side effects while increasing tumor exposure addresses one of oncology's most persistent challenges.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Sidewinder Therapeutics is an emerging player bringing innovative solutions to the BioTech market.
Growth Stage
Sidewinder Therapeutics has achieved $100M in revenue, demonstrating strong product-market fit.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
80 Acres Farms
80 Acres Farms is a commercial-scale indoor vertical farming company that, following its merger with Soli Organic, operates the largest indoor farming network in North America. The company raised $115
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Honda
Honda Motor Co., Ltd. is a Japanese multinational mobility conglomerate founded in 1948 by Soichiro Honda and Takeo Fujisawa in Hamamatsu, Japan. Starting as a motorcycle manufacturer, Honda expanded
Compare Sidewinder Therapeutics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Sidewinder Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Sidewinder Therapeutics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Sidewinder Therapeutics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →